Kirkland Aller-Fex tablets recalled for impurity specification failure
Perrigo Company is recalling Kirkland Aller-Fex fexofenadine hydrochloride 180 mg tablets nationwide because stability testing found out-of-specification impurity levels in affected lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing/quality defect (out-of-specification impurity). The source text does not report any illnesses or injuries, making this a precautionary recall based on a quality control failure rather than a known harm event.
Plain-English summary
Perrigo Company PLC is recalling Kirkland Aller-Fex fexofenadine hydrochloride tablets, 180 mg, 24-hour antihistamine in 180-count bottles, due to failed impurities and degradation specifications. During stability testing, an out-of-specification result was obtained for impurity A in affected lots.
The recalled product was made in the Czech Republic and packaged by Perrigo at 515 Eastern Ave., Allegan, Michigan 49010, for Costco Wholesale Corporation. The recall affects 42,026 containers distributed nationwide in the USA. Affected lots include: 0HV1246 (expiration 1/1/2022); 0GV1974, 0GV1459 (expiration 2/1/2022); 0HV1438 (expiration 3/1/2022); 0KV2116, 0KV2117 (expiration 5/1/2022); and 0KV2119, 0LV2196, 0MV2203, 0MV2204, 0MV2205 (expiration 6/1/2022).
Consumers who have this product should stop use. Those with questions should contact Costco or consult a healthcare provider.
The recalled product
- Product
- KIRKLAND ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24HR, 180 count bottle, Made in the Czech Republic, Packaged by Perrigo 515 Eastern Ave., Allegan, MI 49010, For Costco Wholesale Corporation. P.O. Box 34535 Seattle, WA 98124-1535, NDC 63981-571-48, U
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Antihistamine / OTC
- Hazard
- Affected units
- 42,026
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot # 0HV1246
- exp 1/1/2022
- 0GV1974
- 0GV1459
- exp 2/1/2022
- 0HV1438
- exp 3/1/2022
- 0KV2116
- 0KV2117
- exp 5/1/2022
- 0KV2119
- 0LV2196
- 0MV2203
- 0MV2204
- 0MV2205
- exp 6/1/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17